Ligand Pharmaceuticals, Inc.
http://www.ligand.com
Questions?
Please contact Sales at: (212) 520-2765 or email PharmaNewsSales@informa.com
Latest From Ligand Pharmaceuticals, Inc.
HLTH 2022 Roundup: CEOs Of BD And Google Cloud On Innovation, Interoperability, AI
In this second roundup of HLTH, which drew more than 9,000 attendees to Las Vegas from 13-16 November, Medtech Insight highlights presentations from the CEOs of BD and Google Cloud and insights from an interview with BD’s CEO Tom Polen.
HLTH 2022 Roundup: Mirvie, Grail, Biofourmis, Komodo Health, Babson Diagnostics
This year’s annual HLTH meeting drew more than 9,000 people to Las Vegas from 13-16 November and hundreds of exhibitors. In this first part of a two-part roundup, Medtech Insight highlights interviews with C-suite executives at Mirvie, Grail, Biofourmis, Komodo Health and Babson Diagnostics.
HLTH Conference Promises Festival Vibe On One Big Stage; Health Equity, Women’s Health, Digital Health
HLTH is expected to draw more than 9,500 attendees to Las Vegas from 13-16 November.
Medtech Challenged To Build On 2021 Amid Threats Of Recession: Views From Industry Leaders
Strong headwinds beset the medtech industry as 2022 draws to a close, including supply chain, fundraising and labor shortages. However, optimism prevailed among medtech industry leaders discussing EY’s annual Pulse of the Industry medical technology report and related topics at AdvaMed’s 2022 MedTech Conference.
Company Information
- Industry
-
Pharmaceuticals
-
Drug Delivery
- Site Specific
-
Drug Delivery
-
Biotechnology
- Drug Discovery Tools
- Transgenics
-
Large Molecule
- Antibodies
- Other Names / Subsidiaries
-
- Ab Initio Biotherapeutics
- Crystal Bioscience, Inc.
- CyDex Pharmaceuticals, Inc.
- Icagen Pharmaceuticals, Inc.
- Metabasis Therapeutics, Inc.
- Neurogen Corporation
- Pharmacopeia, Inc.
- Pfenex Inc.
- Verrow Pharmaceuticals, Inc.
- Vernalis Group plc
- Cita NeuroPharmaceuticals
- Taurus Biosciences LLC
- xCella Biosciences, Inc.